NCT00217230View on ClinicalTrials.gov

Trial To Assess Safety And Efficacy Of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) In Adults Aged 60 Years And Older

PHASE3CompletedINTERVENTIONAL

Enrollment

3,000

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

November 30, 2001

Conditions

Influenza

Interventions

BIOLOGICAL

CAIV-T

Trial Locations (1)

7505

Department of Family & Primary Care, Faculty of Medicine, University of Stellenbosch, Tygerberg

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

MedImmune LLC

INDUSTRY